Drug Type CAR-NKT |
Synonyms GT 737, GT-737 |
Target |
Action inhibitors |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), CD70 inhibitors(CD70 antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory acute myeloid leukemia | Phase 1 | China | 01 Jul 2026 | |
| Relapsing acute myeloid leukemia | Phase 1 | China | 01 Jul 2026 |





